ArticleThe American journal of cardiology2020

Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation.

Lanting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.